Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Androgen therapy in AIDS wasting.

A S Dobs1

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.

Bailliere'S Clinical Endocrinology and Metabolism
|May 20, 1999
PubMed
Summary

Testosterone therapy may benefit HIV-infected individuals with low androgen levels, potentially improving body composition and quality of life. However, studies remain inconclusive on its widespread effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testosterone use and shorter electrocardiographic QT interval duration in men living with and without HIV.

HIV medicine·2020
Same author

Pre-diabetes and serum sex steroid hormones among US men.

Andrology·2016
Same author

Racial variation in sex steroid hormone concentration in black and white men: a meta-analysis.

Andrology·2014
Same author

Low free testosterone in HIV-infected men is not associated with subclinical cardiovascular disease.

HIV medicine·2012
Same author

Hip bone geometry in HIV/HCV-co-infected men and healthy controls.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2011
Same author

Effect of high-dose isoflavones on cognition, quality of life, androgens, and lipoprotein in post-menopausal women.

Journal of endocrinological investigation·2009

Area of Science:

  • Endocrinology
  • Infectious Diseases
  • HIV/AIDS Research

Background:

  • Hypogonadism affects approximately 30% of men with HIV, stemming from chronic illness, HIV infection, and medications.
  • Low testosterone levels in HIV are linked to endocrine organ invasion and wasting syndrome, impacting lean body mass.

Purpose of the Study:

  • To evaluate the potential benefits of testosterone therapy in HIV-infected individuals with wasting or low androgen concentrations.
  • To assess the impact of testosterone supplementation on body composition, quality of life, and metabolic outcomes.

Main Methods:

  • Review of existing studies on testosterone therapy in HIV-infected populations.
  • Analysis of short-term study data regarding metabolic outcomes and androgen deficiency.

Main Results:

  • Current studies on testosterone therapy in HIV-infected individuals have yielded inconclusive results.
  • Not all studies demonstrate a statistically significant benefit in weight, muscle mass, or quality of life.

Conclusions:

  • While beneficial effects are not definitively proven, short-term data suggest testosterone supplementation may improve metabolic outcomes in HIV-infected men with androgen deficiency.
  • Further research is needed to clarify the risks and benefits of testosterone therapy in this population, with close monitoring of prostate and lipid levels.

Related Experiment Videos